1 Current dietary assessment methods including food-frequency questionnaires (FFQs), 24-hour 2 recalls and weighed food diaries are associated with many measurement errors. In an attempt to 3 overcome some of these errors, dietary biomarkers have emerged as a complimentary approach to 4 these traditional methods. Metabolomics has developed as a key technology for the identification of 5 new dietary biomarkers and to date, metabolomics based approaches have led to the identification 6 of a number of putative biomarkers. The three approaches generally employed when using 7 metabolomics in dietary biomarker discovery are; i) acute interventions where participants consume 8 specific amounts of a test food, ii) cohort studies where metabolic profiles are compared between 9 consumers and non-consumers of a specific food and iii) the analysis of dietary patterns and 10 metabolic profiles to identify nutritypes and biomarkers. The present review critiques the current 11 literature in terms of the approaches used for dietary biomarker discovery and gives a detailed 12 overview of the currently proposed biomarkers, highlighting steps needed for their full validation.
new dietary biomarkers. Metabolomics provides a powerful approach for the comprehensive 48 description of all low molecular weight molecules present in biological samples (16) . In 49 metabolomics research the analytical platforms predominantly used are nuclear magnetic resonance 50 (NMR) spectroscopy and mass spectrometry (MS) coupled with a chromatographic step, for identify correlations between NMR spectral regions and SSB intakes in the cohort study. A panel 139 of 4 biomarkers; formate, citrulline, taurine and isocitrate were identified as markers of SSB intake. 140 Following the acute consumption of the SSB all 4 metabolites were shown to increase in the urine 141 and the panel of biomarkers were successfully identified in the SSB (31) . Another study using this 142 cohort study approach, analysed the correlations between serum profiles and dietary data collected 143 using FFQs in participants from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer 144 Screening Trial (32) . The application of untargeted metabolomics to this epidemiologic data set 145 detected 39 metabolites of known identity that were correlated with a total of 13 dietary groups, for 146 example citrus intake was associated with stachydrine, chiro-inositol, scyllo-inositol and N-methyl 147 proline, fish with 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, DHA and EPA, peanut 148 intake with tryptophan betaine and 4-vinylphenol sulfate and coffee intake was associated with 149 trigonelline-N-methylnicotinate and quinate (32) . To complicate interpretation further, the intake of 150 foods is highly correlated making identification of specific biomarkers difficult and this highlights 151 the need for the validation of biomarkers. The majority of biomarkers identified using cohort 152 studies have been predominantly identified in urine, this study demonstrates the potential use of 153 serum samples in dietary biomarker discovery. However, the proposed biomarkers identified are 154 only based on associations and some biomarkers were not food specific, for example DHA was correlated with fish and rice intake. Further validation in intervention studies is therefore necessary 156 to demonstrate responsiveness to intake. 157 Wittenbecher and colleagues also demonstrated the use of serum samples when identifying 158 biomarkers of red meat intake in a subset of participants from the European Prospective 159 Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort (n=2047) (33) . Total red meat 160 consumption was assessed using FFQs and serum samples were analysed using a targeted 161 metabolomics approach. Ferritin, glycine, 4 diacyl phosphatidylcholines, 11 acylalkyl 162 phosphatidylcholines, 2 lysophosphatidylcholines and 2 sphingomyelins were associated with total 163 red meat consumption and 6 of these biomarkers were also found to be associated with type 2 164 diabetes risk (33) . This is the first study evaluating a large set of metabolites as potential mediators of 165 the association between red meat intake and diabetes risk, however, dietary information relied on 166 estimates of habitual consumption over the past year by FFQs and metabolites were measured at a 167 single time point. Furthermore, total red meat was defined as processed and unprocessed meat and 168 therefore did not identify biomarkers of specific types of meat. Additional study is essential to 169 validate the biomarkers identified and to further dissect such relationships with disease risk.
170
Biomarkers of bread intake have also been investigated in 155 subjects from the PERIMED 171 study (34) . A 137-item FFQ was used to stratify subjects into three groups: non-consumers of bread 172 (n = 56), white-bread consumers (n = 48) and whole-grain bread consumers (n = 51). Fasting urine glucuronide was also found to be more abundant in whole-grain bread consumers (34) . The 178 biomarkers identified are based on a FFQ; therefore further validation is essential to demonstrate a 179 direct relationship with bread consumption. The third approach; analysing dietary patterns and metabolomic profiles to identify nutritypes (ie, 183 metabolic profiles that reflect dietary intake) and biomarkers have been demonstrated by a number 184 of research groups (see Table 3 ). One of the first examples emerged from our laboratory when a k-185 means cluster analysis was performed on self-reporting dietary data and 3 distinct dietary patterns, 186 which were associated with unique food intakes were identified (35) . Dietary clusters were reflected 187 in the urinary metabolomic profiles of the 125 participants and a number of metabolites were 188 identified and linked to the intake of specific food groups (35) . These nutritypes have the potential to 189 aid dietary assessment by unobjectively classifying people into certain dietary patterns. Further work within our research group, applying the concept of using biomarkers to reflect dietary 191 patterns, has focused on lipidomics, a subfield of metabolomics that concentrates on the global 192 study of lipids (36) . Dietary data, measured by FFQs and lipid profiles measured from serum 193 samples, in 34 Metabolic Challenge Study (MECHE) participants were used for this analysis. PCA 194 reduced lipid profiles into lipid patterns and these were regressed against dietary data to identify 195 biomarkers related to the intake of certain foods and nutrients. 6 lipid patterns were identified 196 including lipid pattern 1 which was found to be highly predictive of dietary fat intake (AUC of 197 0.82), lipid pattern 4 which was highly predictive of alcohol intake (AUC=0.81) and lipid pattern 6 198 which had a reasonably good ability to predict dietary fish intake (AUC=0.76).
199
Lysophosphatidylcholine alkyl C18:0 (LPCeC18:0) was identified as a potential biomarker of 200 alcohol consumption and lysophosphatidylethanolamine acyl C18:2 (LPEaC18:2) and 201 phoshatidylethanolamine diacyl C38:4 (PEaaC38:4) were identified as potential biomarkers of fish 202 intake (36) . This approach demonstrates the utility of serum in the identification of key dietary 203 factors that influence the lipidomic profile. However, again validation of the biomarkers through 204 use of intervention studies is needed.
205
Most recently, Andersen and colleagues used an untargeted metabolomics approach to 206 distinguish between two dietary patterns with the purpose of developing a compliance measure (37) .
207
In a parallel intervention study 181 participants were randomly assigned to follow a New Nordic misclassification rate of 19% (37) . Metabolites characterising the ADD diet and the NND diet are 212 listed in Table 3 . This study demonstrates the potential of metabolomics in discovering biomarkers 213 indicative of dietary patterns but furthermore it highlights a promising approach that may be used to 214 develop compliance measures that cover the most important discriminant metabolites of complex 215 diets.
217
Limitations of current approaches/study designs 218 In general, metabolomics based approaches have produced reasonably robust models for dietary 219 biomarker identification. However, following the discovery of any biomarker, validation in an 220 independent study is critical to enable the generalisability of the results. This validation step is or the analytic methodology could skew biomarker measures of dietary intake (38) . For many of the study designs discussed, validation of the biomarker is often absent, making it difficult for the 225 translation of these biomarkers into practice. 226 It has been proposed that the confirmation of dietary biomarkers should occur in two stages, 227 firstly the dose-response effect should be included in intervention studies and secondly the 228 suitability of the candidate biomarker in a free-living population should be investigated using a 229 (controlled) habitual diet (39) . Evaluation of the dose-response relationship is critical as it allows for 230 the assessment of the suitability of the biomarker over a range of intakes (20) . Unfortunately, in 231 many studies, this important step is often absent. Biomarkers identified using samples from cohort 232 studies do not assess the direct relationships of food amounts consumed and levels of biomarkers 233 and do not demonstrate responsiveness to intakes, therefore the relationship is only an association 234 (16) . Such studies should ideally be combined with intervention studies to demonstrate direct within the cross-sectional study only one compound annotated with MS/MS support was identified 247 using the 3-day food records and there were no metabolites that significantly separated groups 248 based on FFQ data (40) . This therefore demonstrates the drawbacks of using self-reported data in 249 dietary biomarker discovery. Furthermore, when using cohort studies to identify or confirm 250 biomarkers it is imperative that it is acknowledged that many of the foods consumed are highly 251 correlated and therefore biomarkers identified may not be specific to the particular food of interest 252 (20) . Following identification of putative biomarkers from cohort studies we recommend that the 253 relationship is confirmed using an intervention study in a dose-response manner where the 254 sensitivity and specificity of the biomarkers can also be assessed. The importance of such a step is 255 key to the validation of the biomarkers and important to support their use.
256
Use of acute and medium term interventions is not without limitations in terms of dietary 257 biomarker identification: many of the biomarkers identified using this approach are markers of 258 acute intake. For example proline betaine is excreted rapidly in urine and excretion is almost complete ≤24 h (22) . These acute biomarkers may therefore only be valid for people that regularly 260 and frequently consume the particular foods. The identification of dietary biomarkers that reflect 261 habitual intake requires longer-term studies. Furthermore, it must also be noted that the majority of 262 the acute and medium term intervention study designs involve only a small number of participants 263 (22; 24; 41) . The proposed dietary biomarkers identified using these approaches therefore cannot 264 always be extrapolated to population studies in free-living individuals. However, this can be in part 265 be dealt with by confirmation in cohort studies with a diverse range of characteristics.
266
While the above describes limitations in study designs, there is also the need for 267 development of databases and software tools to advance the interpretation of metabolomics results 268 and therefore enhance the utility of dietary biomarkers in nutrition research. Current databases such 269 as the Human Metabolome Database (HMDB) provides access to an online database containing 270 detailed information about small molecule metabolites (>40,000) found in the human body (42) . 271 Since it was first described in 2007, it is constantly being expanded and updated and has become a 272 valuable resource that contains spectroscopic, quantitative, analytic and physiological information 273 about human metabolites (42) . The Food Metabolome Database (FooDB), is another database of 274 >28,000 food constituents that contains information about food sources and food concentrations (43) . 275 This resource provides an aid for the identification of new metabolites that are reflective of food 276 intake. While this resource is valuable, the identification of metabolites originating from food 277 remains difficult and there is a need for sharing of databases to aid identification. Most recently, a 278 comprehensive and electronically accessible human urine metabolome database, which includes 279 quantitative concentrations of metabolites in urine samples was established (44) . This database also 280 represents a significant development and resource for biomarker identification and quantification.
281
Other new software tools include BAYESIL, this system provides fully automated and fully 282 quantitative NMR-based metabolomics of complex mixtures (45) . This will have a significant impact 283 on NMR spectroscopy and NMR-based metabolomics. The use of dietary biomarkers in nutrition research holds great promise. However, prior to having a 289 suite of reliable dietary biomarkers that could be used in nutrition research a number of validation 290 steps need to considered. Furthermore, the challenges identified in this review need to 291 acknowledged and addressed. Appropriate validation steps are essential, otherwise the robustness of 292 biomarkers will remain uncertain and the translation of these biomarkers into practice will be 293 challenging. Longer-term studies are also needed for the identification of dietary biomarkers reflective of habitual dietary intake. Until well validated biomarkers are identified it is unlikely we 295 will see uptake by the research community of the emerging biomarkers. The challenge for the 296 researchers working in this field, in the coming years, will be to develop a suite of well validated 297 biomarkers. To this end the JPI funded programme FoodBall will address some of these issues and 298 pave the way forward (http://foodmetabolome.org/). They may also have the potential for the 299 assessment of compliance to dietary interventions in both a clinical and a research setting.
300
Ultimately these dietary biomarkers will be used to further elucidate the proposed links between 301 certain foods and disease.
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The authors would like to acknowledge the following funding: FP7 Project NutriTech (289511), 305 SFI (14/JP-HDHL/B3075) and ERC (647783). O'Gorman et al. (36) 5 dietary patterns (e.g. energy intake, plant versus animal based diet) PCA Fasting plasma NMR Energy intake; greater concentrations of lipids related high energy intake, higher circulating phosphatidycholine related to lower energy intake. Animal based diet; higher concentrations of lysine, arginine, glutamine/glutamate, threonine, aspartate/asparagine,citrate and polyol compounds.
Peré-Trepat et al. (70) New Nordic Diet (NND) and an Average Danish Diet (ADD) 24 h urine UPLC-qTOF-MS NND diet; TMAO, hippuric acid, hydroquinoneglucuronide, (2-oxo-2,3-dihydro-1H-indol-3-yl)acetic acid and 3,4,5,6-tetrahydrohippurate. ADD diet; pyrraline, glucuronide conjugated products, theobromine, 7-methyluric acid, 3,7-dimethyluric acid, 7-methylxanthine, 6-amino-5-[N-methylformylamino]-1-methyluracil, proline betaine and glucuronides of perillic acid.
Andersen et al. (37) Dietary patterns e.g. high intake of butter/low intake of margarine, high intake of red meat and fish/low intake of whole-grain bread, tea and coffee RRR Fasting serum FIA-MS/MS High intake of butter and low intake of margarine; acylcarnitines, acyl-alkyl-phosphatidylcholines, lysophosphatidylcholines and hydroxy-sphingomyelins. High intake of red meat and fish and low intake of whole-grain bread and tea; hexose and phosphatidylcholines.
Floegal et al. (71) PCA, principal component analysis. ESI, electrospray ionisation. MS, mass spectrometry. LPCeC18:0, lysophosphatidylcholine alkyl C18:0. LPEaC18:2, lysophosphatidylethanolamine acyl C18:2. PEaaC38:4, phoshatidylethanolamine diaclyl C38:4. TMAO, trimethylamine-N-oxide. NMR, nuclear magnetic resonance. UPLC, ultra-performance liquid chromatography. qTOF, quadrupole time-of-flight. RRR, reduced rank regression. FIA, flow injection analysis.
